Sclerosis is a peer-reviewed english-language open-access journal published by MDPI AG in Switzerland, operating under an open-access model since 2023. The journal covers Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system and Dermatology.
Authors are required to pay an article processing charge to publish in Sclerosis; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY license (see other journals using this license).
To date, Sclerosis has published 91 articles. Articles are minted with DOIs through the prefix 10.3390.
Keywords
sclerosis, atherosclerosis
At a glance
- Publisher
- MDPI AG
- Country
- Switzerland
- Primary language
- English
- License
- CC BY
- Peer review
- Anonymous peer review
- OA since
- 2023
- DOI prefix
10.3390
ISSN
- electronic
- 2813-3064
Frequently asked questions
Is Sclerosis peer-reviewed?
Yes — Sclerosis operates a Anonymous peer review review process.
Does Sclerosis charge an article processing charge (APC)?
Yes — refer to the journal's APC page for the current rate. A waiver policy is available for eligible authors.
What subjects does Sclerosis publish?
Sclerosis publishes research in Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry: Neurology. Diseases of the nervous system and Dermatology.
What languages does Sclerosis accept?
Sclerosis accepts manuscripts in English.
What is the ISSN of Sclerosis?
ISSN:
2813-3064 (electronic).How do I submit a manuscript to Sclerosis?
Submit through the journal's official portal: visit submission page →